The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale
In their article, Skipper and colleagues report the results of trial of hydroxychloroquine for patients presenting with nonsevere COVID-19. The editorialists discuss the findings and the need to examine carefully not only what we know about hydroxychloroquine and COVID-19 but also how we learned it, disseminated it, and put it into practice.
Schluger, N. W. (2020). The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale. Annals of Internal Medicine, 173 (8), 662-663. https://doi.org/10.7326/M20-5041